La terapia chirurgica del carcinoma del polmone non-microcitoma localmente avanzato.

Translated title of the contribution: Surgical therapy of locally advanced non-small cell lung carcinoma

M. Martelli, G. Cardillo, M. Lopergolo, F. Facciolo

Research output: Contribution to journalArticlepeer-review


Experience during the past 10 years has shown up different opinions on the surgical treatment of patients with stage III non-small cell lung cancer. In the light of high resectability and survival rates (respectively 80.8% and 40% at 2 years in the experience of the Southwest Oncology Group) produced with neoadjuvant therapy (followed by surgery) it appears to be an appealing therapeutic option. Until recently, there have been no large prospective randomized phase III trials to answer the question of whether neoadjuvant therapy is superior to other treatment modalities (surgical resection alone; non-surgical treatment).

Translated title of the contributionSurgical therapy of locally advanced non-small cell lung carcinoma
Original languageItalian
Pages (from-to)30-33
Number of pages4
JournalChirurgia Italiana
Issue number3
Publication statusPublished - 1995

ASJC Scopus subject areas

  • Surgery


Dive into the research topics of 'Surgical therapy of locally advanced non-small cell lung carcinoma'. Together they form a unique fingerprint.

Cite this